Familial Dilated Cardiomyopathy Caused by an Alpha-Tropomyosin Mutation: The Distinctive Natural History of Sarcomeric DCM

Familial Dilated Cardiomyopathy Caused by an Alpha-Tropomyosin Mutation: The Distinctive Natural History of Sarcomeric DCM

Bibliografische gegevens
Hoofdauteurs:	Lakdawala, N, Dellefave, L, Sparks, E, Cirino, A, Depalma, S, Funke, B, Colan, S, Watkins, H, Robinson, P, Redwood, C, Seidman, C, Seidman, J, McNally, E, Ho, C
Formaat:	Conference item
Gepubliceerd in:	2009

Gelijkaardige items

Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy.
door: Lakdawala, N, et al.
Gepubliceerd in: (2010)

Functional effects of mutations in troponin T and tropomyosin which cause dilated cardiomyopathy
door: Robinson, P, et al.
Gepubliceerd in: (2003)

[Abnormal tropomyosin function in ATPase cycle in hypertrophic and dilated cardiomyopathies].
door: Borovikov, I, et al.
Gepubliceerd in: (2013)

Emerging Concepts of Mechanisms Controlling Cardiac Tension: Focus on Familial Dilated Cardiomyopathy (DCM) and Sarcomere-Directed Therapies
door: R. John Solaro, et al.
Gepubliceerd in: (2024-05-01)

Structure-function relationships of eight mutations in troponin and tropomyosin that cause dilated cardiomyopathy
door: Mirza, M, et al.
Gepubliceerd in: (2004)

Mutations in tropomyosin that cause DCM, affect cooperativity of cardiac muscle thin filaments
door: Marston, S, et al.
Gepubliceerd in: (2007)

Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.
door: Robinson, P, et al.
Gepubliceerd in: (2007)

Alpha-tropomyosin mutations in inherited cardiomyopathies.
door: Redwood, C, et al.
Gepubliceerd in: (2013)

Dilated cardiomyopathy mutations in alpha-tropomyosin inhibit its movement during the ATPase cycle.
door: Borovikov, Y, et al.
Gepubliceerd in: (2009)

Two DCM mutations in cardiac tropomyosin alter thin filament function by different mechanisms
door: Marston, S, et al.
Gepubliceerd in: (2007)

Myosin sequestration regulates sarcomere function, cardiomyocyte energetics, and metabolism, informing the pathogenesis of hypertrophic cardiomyopathy
door: Toepfer, CN, et al.
Gepubliceerd in: (2020)

Hypertrophic and dilated cardiomyopathycausing mutations of troponin and alpha-tropomyosin have opposite effects on thin filament calcium binding
door: Robinson, P, et al.
Gepubliceerd in: (2007)

The effect of the dilated cardiomyopathy-causing mutation Glu54Lys of alpha-tropomyosin on actin-myosin interactions during the ATPase cycle.
door: Borovikov, Y, et al.
Gepubliceerd in: (2009)

Patients with Dilated Cardiomyopathy (DCM) have appropriate myocardial oxygenation response to vasodilator stress
door: Dass Sairia, et al.
Gepubliceerd in: (2013-01-01)

Characterization and natural history of patients with LMNA‐related dilated cardiomyopathy in the phase 3 REALM‐DCM trial
door: Pablo Garcia‐Pavia, et al.
Gepubliceerd in: (2024-12-01)

Personalized care in dilated cardiomyopathy: Rationale and study design of the activeDCM trial
door: Farbod Sedaghat‐Hamedani, et al.
Gepubliceerd in: (2024-12-01)

The effect of mutations in alpha-tropomyosin (E40K and E54K) that cause familial dilated cardiomyopathy on the regulatory mechanism of cardiac muscle thin filaments.
door: Mirza, M, et al.
Gepubliceerd in: (2007)

Dilated cardiomyopathy causing mutations in cardiac troponin T (TNT), cardiac troponin C (TNC), and alpha tropomyosin (TM) reduce CA(2+) sensitivity and maximum calcium activation
door: Redwood, C, et al.
Gepubliceerd in: (2004)

Prognostic Value of Circulating Fibrosis Biomarkers in Dilated Cardiomyopathy (DCM): Insights into Clinical Outcomes
door: Elham Kayvanpour, et al.
Gepubliceerd in: (2024-09-01)

Using fluorescence emission spectroscopy to asses the Ca2+ affinity of reconstituted troponin and thin filaments containing cardiomyopathy causing mutations of troponin and alpha-tropomyosin
door: Robinson, P, et al.
Gepubliceerd in: (2007)

Contribution of hypoxia-inducible factor 1alpha to pathogenesis of sarcomeric hypertrophic cardiomyopathy
door: Sarala Raj Murthi, et al.
Gepubliceerd in: (2025-01-01)

Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes
door: Walsh, R, et al.
Gepubliceerd in: (2017)

Prognostic Impact of the Extent, Location, and Pattern of Late Gadolinium Enhancement (LGE) in Dilated Cardiomyopathy (DCM) and Isolated Left Ventricular Dilation Patients
door: Trecy Gonçalves, MD, et al.
Gepubliceerd in: (2024-01-01)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
door: Hudsmith, L, et al.
Gepubliceerd in: (2006)

Sarcomere gene variants did not improve cardiac function in pediatric patients with dilated cardiomyopathy from Japanese cohorts
door: Keiichi Hirono, et al.
Gepubliceerd in: (2024-12-01)

Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy.
door: Geier, C, et al.
Gepubliceerd in: (2008)

Dilated cardiomyopathy and the desmin gene.
door: Mayosi, B, et al.
Gepubliceerd in: (2000)

Sarcomere mutation negative hypertrophic cardiomyopathy is associated with ageing and obesity
door: Alejandro E de Feria, et al.
Gepubliceerd in: (2021-02-01)

Identification and functional analysis of cardiac troponin I as a novel disease gene in autosomal dominant familial dilated cardiomyopathy
door: Carballo, S, et al.
Gepubliceerd in: (2006)

Comparison of the functional effects of mutations in troponin T which cause dilated and hypertrophic cardiomyopathies
door: Robinson, P, et al.
Gepubliceerd in: (2002)

Plakophilin-2 truncating variants impair cardiac contractility by disrupting sarcomere stability and organization
door: Zhang, K, et al.
Gepubliceerd in: (2021)

In vitro motility studies of HCM and DCM mutations in cardiac muscle actin
door: Dyer, E, et al.
Gepubliceerd in: (2007)

HCM and DCM mutations in thin filament proteins have opposite effects on in vitro motility
door: Marston, S, et al.
Gepubliceerd in: (2002)

Hypertrophic cardiomyopathy mutations in MYBPC3 dysregulate myosin
door: Toepfer, C, et al.
Gepubliceerd in: (2019)

Effects of DCM mutations in thin filament regulatory proteins on contractile function
door: Robinson, P, et al.
Gepubliceerd in: (2005)

Functional investigation of beta-tropomyosin mutations that cause congenital skeletal myopathies
door: Piers, A, et al.
Gepubliceerd in: (2011)

Effect of mutation Arg91Gly on the thermal stability of β-tropomyosin
door: Nevzorov, I, et al.
Gepubliceerd in: (2008)

HCM and DCM mutations in thin filament proteins have opposite effects on regulation of contractility in vitro
door: Redwood, C, et al.
Gepubliceerd in: (2003)

Effect of Tricin on cardiomyocyte damage caused by diabetic cardiomyopathy (DCM)
door: Rong Yu, et al.
Gepubliceerd in: (2024-11-01)

A Review on the Natural Products in Treatment of Diabetic Cardiomyopathy (DCM)
door: Pengyu Yao, et al.
Gepubliceerd in: (2024-05-01)